Orange Book product · Generic (ANDA)
CONJUGATED ESTROGENS
ESTROGENS, CONJUGATED
Generic (ANDA)ANDA 214023TE ABRX NOVAST LABS
At a glance
Oct 15, 2025
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 15, 2025
8 mo ago
Exclusivity ends · CGT
FDA marketing exclusivity
Apr 15, 2026
2 mo ago
Today
Pharmaceutical detail
Active ingredient
ESTROGENS, CONJUGATED
Strength
0.9MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 214023
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ESTROGENS, CONJUGATED
Marketing exclusivity (1)
- CGTFDA marketing exclusivity
Apr 15, 2026
2 mo ago
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
